SP-100207

N/A

Report date: 2026/03/17 20:00:15
NME

Base Information

Drug NameSP-100207
Drug Alias NameNF-kappaB/AP-1 inhibitor (Signal)anti-inflammatories (Signal)SP-100075SP-100207
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex modulators
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSignal Research Division
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSignal Research Division
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A